as on December 26, 2025 at 11:39 pm IST
Day's Low
Day's High
0.57%
Downside
0.28%
Upside
52 Week's Low
52 Week's High
37.48%
Downside
5.20%
Upside
Check Biogen Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$25.9B
EPS (TTM)
15.0621
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.19%
PE Ratio (TTM)
16.07
Industry PE ratio
17.123164556962024
PEG Ratio
5.0844
EBITDA
3.4B
Revenue (TTM)
10.1B
Profit Margin
15.98%
Return On Equity TTM
9.31%
Track how Biogen Inc. P/E has moved over time to understand its valuation trends.
Biogen Inc. in the last 5 years
Lowest (7.78x)
June 30, 2025
Today (16.07x)
December 26, 2025
Industry (17.12x)
December 26, 2025
Highest (18.33x)
June 30, 2023
Today’s Price to Earnings Ratio: 16.07x
Compare market cap, revenue, PE, and other key metrics of Biogen Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $25.9B | -29.15% | 16.07 | 15.98% | |
| BUY | $965.5B | 546.21% | 52.64 | 30.99% | |
| BUY | $406.3B | 122.63% | 175.49 | 4.00% | |
| BUY | $500.6B | 36.28% | 20.08 | 27.26% | |
| BUY | $265.9B | 32.83% | 13.9 | 29.63% |
The Biogen Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Biogen Inc. investment value today
Current value as on today
₹1,22,706
Returns
₹22,706
(+22.71%)
Returns from Biogen Inc. Stock
₹17,418 (+17.42%)
Dollar Returns*
₹5,287 (+5.29%)
Based on 42 analysts
71.43%
Buy
28.57%
Hold
0.00%
Sell
Based on 42 analysts, 71.43% of analysts recommend a 'BUY' rating for Biogen Inc.. Average target price of $180.69
Get share price movements and forecasts by analysts on Biogen Inc..
What analysts predicted
2.59%UPSIDE
Target Price
$180.69
Current Price
$176.01
Analyzed by
42 Analysts
Target
$180.69
Biogen Inc. target price $180.69, a slight upside of 2.59% compared to current price of $176.01. According to 42 analysts rating.
Search interest for Biogen Inc. Stock has increased by 23% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:23% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 02 December
Wed, 03:41 AM
-Biogen shares rose 15% in a month, with optimism around pipeline and efficiency despite a challenging long-term performance.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 3 months, BIIB stock has moved up by 28.4%
Against Peers
![]()
In the last 1 year, Johnson & Johnson has given 42.7% return, outperforming this stock by 25.1%
Against Peers
![]()
In the last 3 years, Eli Lilly And Company has given 17.1% return, outperforming this stock by 53.9%
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 2.64B → 2.45B (in $), with an average decrease of 7.2% per quarter
Profit Down
![]()
Netprofit is down for the last 2 quarters, 634.8M → 466.5M (in $), with an average decrease of 26.5% per quarter
| Organisation | Biogen Inc. |
| Headquarters | 225 Binney Street, Cambridge, MA, United States, 02142 |
| Industry | Health Technology |
| CEO | Mr. Christopher A. Viehbacher |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Christopher A. Viehbacher | President, CEO & Director |
Dr. Priya Singhal M.D., M.P.H. | Executive VP & Head of Development |
Mr. Sean Godbout | Chief Accounting Officer & Global Corporate Controller |
Mr. Guy Hadari | Chief Information Officer |
Mr. Adam Keeney Ph.D. | Executive VP & Head of Corporate Development |
Dr. Ginger Gregory Ph.D. | Executive VP & Chief Human Resources Officer |
Ms. Nicole Murphy | Executive VP and Head of Pharmaceutical Operations & Technology |
Ms. Susan H. Alexander Esq. | Executive VP & Chief Legal Officer |
Ms. Robin C. Kramer | Executive VP & CFO |
Mr. Tim Power M.B.A., Ph.D. | Head of Investor Relations |
Biogen Inc. share price today is $176.01 as on . Biogen Inc. share today touched a day high of $176.5 and a low of $175.
Biogen Inc. share touched a 52 week high of $185.17 on and a 52 week low of $110.04 on . Biogen Inc. stock price today i.e. is trending at $176.01,which is 4.95% down from its 52 week high and 59.96% up from its 52 week low.
Biogen Inc. market capitalisation is $0.03T as on .
Indian investors can start investing in Biogen Inc. (BIIB) shares with as little as ₹89.767 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹897.67 in Biogen Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Biogen Inc. share’s latest price of $176.01 as on December 26, 2025 at 11:39 pm IST, you will get 0.0568 shares of Biogen Inc.. Learn more about
fractional shares .
Biogen Inc. stock has given -29.15% share price returns and 21.6% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?